Dermapharm Holding SE (DMP.DE) Stock
Healthcare · Drug Manufacturers - Specialty & Generic · Member of SDAX
Dermapharm Holding SE (DMP.DE) closed at EUR 38.55 on 2026-10-14, a change of +20.8 % over the past year, with a market capitalization of EUR 1.89B.
Dermapharm Holding SE recent closing prices
| Date | Close (EUR) |
|---|---|
| 2026-10-14 | 38.55 |
| 2026-10-13 | 37.85 |
| 2026-10-12 | 38.30 |
| 2026-10-09 | 38.40 |
| 2026-10-08 | 38.15 |
| 2026-10-07 | 38.90 |
| 2026-10-06 | 38.10 |
The most recent trading day is not shown. For full charts and indicators use the analysis page.
Dermapharm Holding SE key figures
- Previous close
- EUR 38.55 (2026-10-14)
- 1-year change
- +20.8 %
- Market cap
- EUR 1.89B
- Enterprise value
- EUR 2.85B
- P/E ratio (trailing)
- 13.87
- P/E ratio (forward)
- 12.86
- EPS (trailing)
- 2.75
- EPS (forward)
- 2.97
- PEG ratio
- n/a
- Price to book
- 3.51
- Revenue growth
- 4.8 %
- Earnings growth
- 20.5 %
- Dividend per share (trailing)
- 0.88
- Short ratio
- n/a
- Employees
- 3,619
- Analyst consensus (third-party)
- none
Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.
About Dermapharm Holding SE
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
Technical indicators and comparison
Show RSI, MACD, EMA, CCI and ADX for Dermapharm Holding SE and compare it with other stocks.
Analyze DMP.DEAll SDAX stocksStock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell Dermapharm Holding SE shares.